BOULDER, Colo., July 25, 2024 (GLOBE NEWSWIRE) — OnKure, Inc. today announced that Dylan Hartley, Ph.D. has been appointed to the position of Chief Scientific Officer. In this position, Dr. Hartley will lead the company’s research organization. “Dr. Hartley has a deep commitment to innovation and advancing drugs to improve patient care,” said Nicholas Saccomano, […]
Category Archives: Pr Newswire
26
Jul
Jul
Clinical benefit observed among non-small cell lung cancer (NSCLC) patients harboring mutant KRAS (mKRAS) variants in the Phase 2 mecbotamab vedotin (CAB-AXL-ADC) study; AXL tumoral expression highly associated with multiple mKRAS variants Evalstotug (CAB-CTLA-4 antibody) as a monotherapy and in combination with PD-1 continues to provide promising anti-tumor activity with a differentiated safety profile associated […]
26
Jul
Jul
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial results for the first quarter of fiscal year 2025 (FY2025) after […]
26
Jul
Jul
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced it will report second quarter 2024 financial results on Thursday, August 1, 2024, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business […]
Pr Newswire
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
26
Jul
Jul
ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated1 There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transplantation (HSCT) or relapse after FDA ODD and RPDD designations […]
STONE Accounting Group is undergoing a rebranding process to redefine the accounting experience, making excellence not just a standard but a catalyst for success in the dynamic, interconnected world. Rooted in principles of innovation and integrity, this initiative unveils a modern identity emphasizing fostering strategic partnerships, empowering clients globally, and expanding their international presence to […]
HO CHI MINH CITY, Vietnam, July 26, 2024 /PRNewswire/ — In the dynamic landscape of the global economy, businesses are continually seeking strategies to optimize operations, reduce costs, and accelerate time-to-market. Offshore Development Centers (ODCs) have emerged as a compelling solution, offering access to skilled talent pools in cost-effective regions. Saigon Technology, a leader in demystifying ODCs, […]
LONDON, July 26, 2024 /PRNewswire/ — On July 6, the inaugural “Shanghai Summer” International Consumption Season began, inviting global travelers to the Bund for a spectacular summer. Shanghai, a major international gateway, welcomed 2.035 million foreign visitors from January to June this year, nearly triple last year’s figure. With a 98% presence of top international brands, […]
• Requests trading of its shares be suspended as of close of trading July 25, 2024 BEIJING, July 26, 2024 /PRNewswire/ — Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) (“Hollysys” or the “Company”) and Ascendent Capital Partners (“Ascendent”) today announced the completion of the merger (the “Merger”) between Hollysys and entities affiliated with Ascendent, pursuant to the […]
SHANGHAI, July 26, 2024 /PRNewswire/ — Angel Yeast (SH600298), a global leader in yeast manufacturing, recently introduced its yeast protein and innovative application solutions at the Growth Asia 2024 summit, which was co-hosted by leading industry media NutraIngredients and FoodNavigator from July 16 to 18 in Singapore. Angel Yeast showcases innovative yeast protein solutions at Growth […]